The Hill on MSN12h
Johnson To Push Ethics Committee To Keep Gaetz Investigation SEALED, X Users FLEE After Trump Win
Julia Manchester chats with The Hill’s Cate Martel about the latest appointments from President Elect Trump. Cate gives her take on Trump’s decision to tap RFK Jr. to lead Health and Human Services; ...
Futurism15h
Anti-Aging CEO Injects Face With Strange Treatment, Experiences Bizarre Reaction
In his extensive efforts to turn back the clock on his aging, 46-year-old youth-obsessed tech mogul Bryan Johnson injected ...
Eli Lilly, J&J Sue US Over Rejected Changes To Drug Discounting Program
Eli Lilly became the second drugmaker this week to sue the U.S. government for rejecting their proposed changes to a program ...
FiercePharma17h
EU regulators endorse meds from BMS, J&J, Eisai and more—plus a clutch of biosims
Now, it's up to the European Commission to confirm those potential green lights in the coming weeks and months.
Wolfe starts J&J at Outperform, sees growth drivers as ‘best-in-class’
Wolfe Research analyst Alexandria Hammond initiated coverage of Johnson & Johnson (JNJ) with an Outperform rating and $190 price target ...
Johnson & Johnson initiated with an Outperform at Wolfe Research
Wolfe Research analyst Alexandria Hammond initiated coverage of Johnson & Johnson with an Outperform rating and $190 price target ...